BACKGROUND: Nonimmunologic factors have been recently implicated in worse outcomes after kidney transplantation, producing a need to predict the operative risk among kidney recipients. We assessed the predictive value of the Charlson comorbidity index (CCI) among kidney transplant recipients. METHODS: A retrospective study of 223 first deceased-donor kidney transplantations performed from 2000 to 2007 evaluated the role of comorbidities. RESULTS: About 50% of recipients displayed >1 comorbid condition before transplantation; the most frequently reported was diabetes mellitus. Increasing CCI scores significantly affected graft and patient survivals. Crude analysis showed a significant association between CCI >1 and risk of death (hazard ratio [HR], 3.87; 95% confidence interval [CI], 1.06-14.06; P = .04). After adjustment for several covariates, high CCI values remained significantly predictive of posttransplantation outcomes with a HR for death of (12.53; 95% CI, 1.9-82.68; P = .009). CONCLUSIONS: Our predictive model showed a strong association of CCI and patient survival even after adjustment for several clinical covariates. CCI may be used to evaluate patients referred for kidney transplantation who display a significant burden of comorbid conditions that increase the risk of premature death or graft loss.
BACKGROUND: Nonimmunologic factors have been recently implicated in worse outcomes after kidney transplantation, producing a need to predict the operative risk among kidney recipients. We assessed the predictive value of the Charlson comorbidity index (CCI) among kidney transplant recipients. METHODS: A retrospective study of 223 first deceased-donor kidney transplantations performed from 2000 to 2007 evaluated the role of comorbidities. RESULTS: About 50% of recipients displayed >1 comorbid condition before transplantation; the most frequently reported was diabetes mellitus. Increasing CCI scores significantly affected graft and patient survivals. Crude analysis showed a significant association between CCI >1 and risk of death (hazard ratio [HR], 3.87; 95% confidence interval [CI], 1.06-14.06; P = .04). After adjustment for several covariates, high CCI values remained significantly predictive of posttransplantation outcomes with a HR for death of (12.53; 95% CI, 1.9-82.68; P = .009). CONCLUSIONS: Our predictive model showed a strong association of CCI and patient survival even after adjustment for several clinical covariates. CCI may be used to evaluate patients referred for kidney transplantation who display a significant burden of comorbid conditions that increase the risk of premature death or graft loss.
Authors: Michael A Freeman; John R Pleis; Kellee R Bornemann; Emilee Croswell; Mary Amanda Dew; Chung-Chou H Chang; Galen E Switzer; Anthony Langone; Anuja Mittal-Henkle; Somnath Saha; Mohan Ramkumar; Jareen Adams Flohr; Christie P Thomas; Larissa Myaskovsky Journal: Transplantation Date: 2017-06 Impact factor: 4.939
Authors: Michael K Sullivan; Alastair J Rankin; Bhautesh D Jani; Frances S Mair; Patrick B Mark Journal: BMJ Open Date: 2020-06-30 Impact factor: 2.692
Authors: Tamar A J van den Berg; Robert C Minnee; Ton Lisman; Gertrude J Nieuwenhuijs-Moeke; Jacqueline van de Wetering; Stephan J L Bakker; Robert A Pol Journal: Transpl Int Date: 2019-01-02 Impact factor: 3.782
Authors: Nanna von der Lippe; Bård Waldum; Tone-Brit Hortemo Østhus; Anna Varberg Reisæter; Ingrid Os Journal: BMC Womens Health Date: 2014-03-01 Impact factor: 2.809
Authors: Dita Aditianingsih; Besthadi Sukmono; Tjues A Agung; Willy Y Kartolo; Erika S Adiwongso; Chaidir A Mochtar Journal: Anesthesiol Res Pract Date: 2019-11-29
Authors: Danielle E Fox; Robert R Quinn; Paul E Ronksley; Tyrone G Harrison; Hude Quan; David Bigam; A M James Shapiro; Rachel Jeong; Ngan N Lam Journal: Can J Kidney Health Dis Date: 2021-07-09